Novavax: Fourth Covid Vaccine Could Be Approved in the UK
Video Credit: ODN - Duration: 01:22s - Published
Novavax: Fourth Covid Vaccine Could Be Approved in the UK
A fourth coronavirus vaccine could be approved for use in the UK within weeks as late-stage trials suggested it was 89% effective in preventing Covid-19.
The UK has secured 60 million doses of the Novavax jab, which is believed to offer protection against the new UK and South African variants.
Two vaccines have already been rolled out in the UK β from Pfizer and Oxford/AstraZeneca β while a third from Moderna has been approved for use.
The Novavax jab will be delivered in the second half of 2021 if it receives MHRA approval.
Report by Avagninag.
Like us on Facebook at http://www.facebook.com/itn and follow us on Twitter at http://twitter.com/itn
Steven Finn looks back on a career of touring with England, including the low of being dropped on Christmas Day and the high of taking down South Africa. BBC Sport
Executive Director of Federation of Small Businesses Craig Beaumont says he is 'disappointed' with GDP figures showing no growth in the economy, and calls on the government to help boost the number of entrepreneurs.
Report by Etemadil. Like us on Facebook at http://www.facebook.com/itn and follow us on Twitter at http://twitter.com/itn
The NHS is urging friends and family to look out for signs and symptoms of dementia in their loved ones as they meet up over the festive period. Dr Jeremy Isaacs, NHS England's National Clinical Director for Dementia said people can help bring those worries to the attention of a doctor for assessment. Report by Etemadil. Like us on Facebook at http://www.facebook.com/itn and follow us on Twitter at http://twitter.com/itn
Sriram Krishnan, a prominent figure in the tech world with a stellar career at Microsoft, Twitter, Facebook, and more, has been appointed as the Senior Policy Advisor for Artificial Intelligence at the White House. His role will focus on shaping AI policies and ensuring that the United States remains at the forefront of technological innovation. Learn about his journey, his vision for AI, and what this means for Americaβs tech future.
#SriramKrishnan #ArtificialIntelligence #TechLeadership #WhiteHouseAI #USInnovation #AIAdvisor #TechPolicy #AIRevolution #SriramInAI #FutureOfTechnology
Also Read
The Sabarmati Report Twitter Review: What Viewers Are Saying On X :: https://www.oneindia.com/entertainment/the-sabarmati-report-twitter-review-what-viewers-are-saying-on-x-011-3988167.html?ref=DMDesc
X Loses Big: Bluesky And Threads Score Big With Celebs And Users! :: https://www.oneindia.com/international/x-loses-big-bluesky-and-threads-score-big-with-celebs-and-users-3987677.html?ref=DMDesc
Citadel Honey Bunny Twitter Review: What Viewers Are Saying On X :: https://www.oneindia.com/entertainment/citadel-honey-bunny-twitter-review-what-viewers-are-saying-on-x-011-3980565.html?ref=DMDesc
~PR.274~ED.103~HT.336~
Chief Secretary to the Treasury Darren Jones says the Labour government has brought stability back to the economy since high inflation under Liz Truss, and that businesses and working people will be pleased with inflation nearing the 2 per cent target.
Report by Etemadil. Like us on Facebook at http://www.facebook.com/itn and follow us on Twitter at http://twitter.com/itn
Chief Secretary to the Treasury Darren Jones says the Labour government is still committed to stimulating economic growth despite figures from the Office of National Statistics showing the economy recorded no growth in the third quarter of this year. Report by Etemadil. Like us on Facebook at http://www.facebook.com/itn and follow us on Twitter at http://twitter.com/itn
From Delhi schools opening for Classes 9 and 11 to SII seeking trial approval for the Novavax vaccine, here are the top updates on the pandemic. Delhi government on Friday announced the schools for..
Credit: HT Digital Content Duration: 03:20Published
While the Novavax vaccine study is still ongoing, initial results show it is nearly 96% effective against the older coronavirus and nearly 86% effective against the new variant circulating in the UK.